Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
- PMID: 31666112
- PMCID: PMC6822571
- DOI: 10.1186/s13046-019-1454-y
Correction to: Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4
Abstract
In the original publication of this article [1], the author would like to revise Figure 4.
Erratum for
-
Elevated TRIP13 drives the AKT/mTOR pathway to induce the progression of hepatocellular carcinoma via interacting with ACTN4.J Exp Clin Cancer Res. 2019 Sep 18;38(1):409. doi: 10.1186/s13046-019-1401-y. J Exp Clin Cancer Res. 2019. PMID: 31533816 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
